Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
Public ClinicalTrials.gov record NCT00005087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Study of Paclitaxel and Cisplatin in Combination With Split Course Concomitant Hyperfractionated Re-Irradiation in Patients With Recurrent Squamous Cell Cancer of the Head and Neck
Study identification
- NCT ID
- NCT00005087
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Radiation Therapy Oncology Group
- Network
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Not listed
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2000
- Primary completion
- Oct 31, 2004
- Completion
- Oct 31, 2013
- Last update posted
- Nov 16, 2015
2000 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 3
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35294-3300 | — |
| Comprehensive Cancer Institute of Huntsville | Huntsville | Alabama | 35801 | — |
| Huntsville Hospital System | Huntsville | Alabama | 35807 | — |
| MBCCOP - Gulf Coast | Mobile | Alabama | 36688 | — |
| Alabama Oncology, LLC | Montgomery | Alabama | 36106-3657 | — |
| DCH Cancer Treatment Center | Tuscaloosa | Alabama | 35401 | — |
| Foundation for Cancer Research and Education | Phoenix | Arizona | 85013 | — |
| Mount Diablo Medical Center | Concord | California | 94524-4110 | — |
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010-3000 | — |
| Saint Agnes Cancer Center | Fresno | California | 93720 | — |
| California Cancer Center | Fresno | California | 93729-5100 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00005087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2015 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00005087 live on ClinicalTrials.gov.